Reports
Reports
Sale
The global oral thin films market size was valued at USD 3.60 billion in 2023, driven by the increasing prevalence of neurological disorders across the globe. The market is anticipated to grow at a CAGR of 9% during the forecast period of 2024-2032 to achieve a value of USD 7.80 billion by 2032.
Oral thin films are polymers that are water soluble in nature. These polymer strips dissolve when comes in contact of saliva and takes only a few seconds. This technology has already been explored by confectionary market to manufacture mouth freshener strips. Pharmaceutical and healthcare industry is also emphasizing on exploring the potential of using it and manufacturing the drugs and medications for patients in similar category as well. The constituents of these films are water, components are held together by stabilizers, flavors, saliva stimulators, colorants and some more.
Oral thin films (OTFs) have gained significant attention and popularity in the pharmaceutical industry in past years. Oral thin films provide a convenient and patient-friendly alternative to traditional dosage forms like tablets or capsules. They are thin, portable, and do not require water for administration, making them easy to use, particularly for patients who have difficulty swallowing or dislike taking oral medications. The formulation of oral thin films is done to rapidly disintegrate or dissolve in the oral cavity, allowing for quick absorption of the medication. This can lead to a faster onset of action compared to traditional oral dosage forms. This makes them appropriate for medications that need instant relief or quick action.
There are several key trends running in the oral thin films market and some of them include the ongoing research studies on the development of oral thin films to contribute to the development of personalized drug delivery system. Increasing number of retailing pharmacies is also increasing the availability of the oral thin film products which is directly contributing to the global oral thin films market growth. Due to the ongoing research in the field of pharmaceutical industry on oral thin films, development of several different drugs to treat several other diseases and disorders is in process. With the use of active ingredients such as Montelukast, Insulin, Rizatriptan, and Testosterone, Pharmaceutical companies has been trying to develop treatment drugs in the form of oral thin films for dementia, diabetes, migraines, male hypogonadism respectively.
The increasing emphasis on sustainability and eco-consciousness, the pharmaceutical products are also experiencing the positive impact and it is resulting in increasing interest in sustainable packaging for them including oral thin films. Manufacturers are exploring environmentally friendly packaging materials and adopting eco-friendly practices, which align with the broader sustainability trends in the market.
Market Breakup by Products
Market Breakup by Disease Indication
Market Breakup by End User
Market Breakup by Region
The market is witnessing a significant growth and is expected to grow in coming years as well. There several factors driving the market growth includes the increasing prevalence of disability disorders and aging population. The development of oral thin films has been put to use so that aging people who have difficulty swallowing hard size pills and capsules find it convenient to consume their medications in the form of these oral thin films propelling the global oral thin films market growth.
Increasing availability due to the increase in number of retail pharmacies has also escalated growth of the product in the market. Increasing prevalence of neurological disorders has also increased the consumption of drugs and medicines in the form of oral thin films contributing to the growth of the market size.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Products |
|
Breakup by Disease Indication |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Oral Thin Films Market Overview
3.1 Global Oral Thin Films Market Historical Value (2017-2023)
3.2 Global Oral Thin Films Market Forecast Value (2024-2032)
4 Global Oral Thin Films Market Landscape
4.1 Image Guided Surgery: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Image Guided Surgery: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Indications
5 Global Oral Thin Films Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Oral Thin Films Market Segmentation
6.1 Global Oral Thin Films Market by Products
6.1.1 Market Overview
6.1.2 Sublingual Film
6.1.3 Other Products
6.2 Global Oral Thin Films Market by Disease Indication
6.2.1 Market Overview
6.2.2 Opioid Dependence
6.2.3 Nausea and Vomiting
6.2.4 Other Disease Indications
6.3 Global Oral Thin Films Market by End User
6.3.1 Market Overview
6.3.2 Hospital Pharmacies
6.3.3 Retail Pharmacies
6.3.4 Other Distribution Channels
6.4 Global Oral Thin Films Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Oral Thin Films Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Oral Thin Films Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Oral Thin Films Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Oral Thin Films Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Oral Thin Films Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Aquestive Therapeutics Inc.
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 LTS Lohmann Therapie-Systeme AG
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 IntelGenx Corp.
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 C.L.Pharm
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 CURE Pharmaceutical
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 ZIM Laboratories Limited
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Viatris
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Sunovion Pharmaceuticals Inc.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 3.60 billion in 2023, driven by the prevalence of neurological disorders.
The market is anticipated to grow at a CAGR of 9% during the forecast period of 2024-2032, likely to reach a market value of USD 7.80 billion by 2032.
The increasing availability of oral thin films due to the increase in number of retail pharmacies in the market is among the major drivers for the market.
The ongoing research in the field of pharmaceutical industry to develop drugs for diseases like migraines, diabetes, dementia and more is one of the major trends among others in the market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The products available in the market are sublingual films and some other products.
The end users in the market include hospital pharmacies, retail pharmacies, other distribution channels.
The indications in the market include blood cancer, solid tumours, among other indications.
Key players involved in the market are Aquestive Therapeutics Inc., LTS Lohmann Therapie-Systeme AG, IntelGenx Corp., C.L.Pharm, CURE Pharmaceutical, ZIM Laboratories Limited, Sunovion Pharmaceuticals Inc., and Viatris.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.